Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

[Paraoxonase: its multiple functions and pharmacological regulation].

Fridman O, Fuchs AG, Porcile R, Morales AV, Gariglio LO.

Arch Cardiol Mex. 2011 Jul-Sep;81(3):251-60. Review. Spanish.

PMID:
21975240
2.

The growing importance of PON1 in cardiovascular health: a review.

Macharia M, Hassan MS, Blackhurst D, Erasmus RT, Matsha TE.

J Cardiovasc Med (Hagerstown). 2012 Jul;13(7):443-53. doi: 10.2459/JCM.0b013e328354e3ac. Review.

PMID:
22673025
3.

The role of genetic (PON1 polymorphism) and environmental factors, especially physical activity, in antioxidant function of paraoxonase.

Otocka-Kmiecik A, Orłowska-Majdak M.

Postepy Hig Med Dosw (Online). 2009 Dec 30;63:668-77. Review.

4.

The role of paraoxonase 1 in the detoxification of homocysteine thiolactone.

Jakubowski H.

Adv Exp Med Biol. 2010;660:113-27. doi: 10.1007/978-1-60761-350-3_11. Review.

PMID:
20221875
6.

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN.

J Clin Invest. 1998 Apr 15;101(8):1581-90.

7.

Paraoxonase 1 and homocysteine metabolism.

Perła-Kaján J, Jakubowski H.

Amino Acids. 2012 Oct;43(4):1405-17. Epub 2012 May 29. Review.

PMID:
22643843
8.

Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences.

Aviram M, Rosenblat M.

Curr Opin Lipidol. 2005 Aug;16(4):393-9. Review.

PMID:
15990587
9.
10.

[Paraoxonase--important enzyme of the lipid metabolism and potential ally in the antiatherosclerotic treatment].

Sapian-Raczkowska B, Rabczyński M, Adamiec R.

Pol Merkur Lekarski. 2010 Nov;29(173):325-7. Review. Polish.

PMID:
21268919
11.

Homocysteine, Paraoxonase-1 and Vascular Endothelial Dysfunction: Omnibus viis Romam Pervenitur.

Eren E, Ellidag HY, Aydin O, Yılmaz N.

J Clin Diagn Res. 2014 Sep;8(9):CE01-4. doi: 10.7860/JCDR/2014/7827.4773. Epub 2014 Sep 20. Review.

12.

Paraoxonase 1 protects against protein N-homocysteinylation in humans.

Perla-Kaján J, Jakubowski H.

FASEB J. 2010 Mar;24(3):931-6. doi: 10.1096/fj.09-144410. Epub 2009 Oct 30.

13.

The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

She ZG, Chen HZ, Yan Y, Li H, Liu DP.

Antioxid Redox Signal. 2012 Mar 15;16(6):597-632. doi: 10.1089/ars.2010.3774. Epub 2011 Oct 18. Review.

15.

The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention.

Mackness MI, Durrington PN, Mackness B.

Am J Cardiovasc Drugs. 2004;4(4):211-7. Review.

PMID:
15285696
16.
17.
18.

Does paraoxonase play a role in susceptibility to cardiovascular disease?

Aviram M.

Mol Med Today. 1999 Sep;5(9):381-6. Review.

PMID:
10462749
19.

Protein homocysteinylation: a new mechanism of atherogenesis?

Bełtowski J.

Postepy Hig Med Dosw (Online). 2005;59:392-404. Review.

20.

Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis.

Liberopoulos EN, Papavasiliou E, Miltiadous GA, Cariolou M, Siamopoulos KC, Tselepis AD, Elisaf MS.

Perit Dial Int. 2004 Nov-Dec;24(6):580-9.

Items per page

Supplemental Content

Write to the Help Desk